AI as a new paradigm for risk-based screening for breast cancer

Field	Value	Language
dc.contributor.author	Houssami, Nehmat
dc.contributor.author	Kerlikowske, Karla
dc.date.accessioned	2023-03-20T00:16:13Z
dc.date.available	2023-03-20T00:16:13Z
dc.date.issued	2022	en_AU
dc.identifier.uri	https://hdl.handle.net/2123/30238
dc.description.abstract	AI may represent a new tool in the risk assessment and screening pathway of breast cancer. To realise its potential, the effect of AI-supported decisions on relevant clinical outcomes must be prospectively evaluated.	en_AU
dc.language.iso	en	en_AU
dc.publisher	Nature research	en_AU
dc.relation.ispartof	Nature Medicine	en_AU
dc.rights	Copyright All Rights Reserved	en_AU
dc.subject	cancer	en_AU
dc.subject	population screening	en_AU
dc.title	AI as a new paradigm for risk-based screening for breast cancer	en_AU
dc.type	Article, Letter	en_AU
dc.identifier.doi	10.1038/s41591-021-01649-3
dc.type.pubtype	Publisher's version	en_AU
usyd.faculty	SeS faculties schools::Faculty of Medicine and Health::Sydney School of Public Health	en_AU
usyd.citation.volume	28	en_AU
usyd.citation.spage	29	en_AU
usyd.citation.epage	30	en_AU
workflow.metadata.only	Yes	en_AU

Associated file/s

There are no files associated with this item.